Smart insulin pump beats daily shots in diabetes trial

NCT ID NCT05923827

Completed Disease control Sponsor: Insulet Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether the Omnipod 5, a tubeless automated insulin pump, works better than multiple daily insulin injections for managing type 1 diabetes. 189 children and adults participated. The main goal was to see if the pump improved blood sugar control (HbA1c) over 13 weeks. The pump automatically adjusts insulin based on continuous glucose monitor readings, aiming for steadier blood sugar levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omnipod 5 System (automated insulin pump)
What this could lead to: If successful, this could provide a more convenient and effective way to manage type 1 diabetes, reducing the burden of multiple daily injections and improving blood sugar levels.
What could go wrong: This is a completed trial, but results may not apply to everyone. The device requires proper use and monitoring, and there is always a risk of pump malfunction or skin reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

CHU Grenoble Aples

Grenoble, France
CHU Rennes

Rennes, France
CHU Toulouse

Toulouse, France
CHU de Nancy

Nancy, France
Centre Hospitalier Universitaire Carémeau de Nîmes

Nîmes, France
Centre Hospitalier Universitaire Côte de Nacre

Caen, France
Centre Hospitalier Universitaire de Reims

Reims, France
Cliniques Universitaires Saint-Luc

Brussels, Belgium
Hospices Civils de Lyon

Lyon, France
Hôpital Necker

Paris, France
Hôpitaux Pédiatriques de Nice CHU-Lenval,

Nice, France
Hôpitaux Universitaires de Marseille Timone

Marseille, France
Manchester University NHS Foundation Trust

Manchester, United Kingdom
Mersey and West Lancashire NHS Teaching Hospitals Trust

Ormskirk, United Kingdom
Oxford Health NHS Foundation Trust

Oxford, United Kingdom
Robert-Debré AP-HP Hospital

Paris, France
Universitaire Ziekenhuizen Leuven

Leuven, Belgium
University Hospitals of Derby & Burton

Derby, United Kingdom
University Hospitals of Leicester NHS Trust

Leicester, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.